Hottest Stocks (Over $10)	Hottest Stocks ($2-$10)	Biggest Losers (Over $10)	Biggest Losers ($2-$10)	Hottest Industries	Hottest Sectors	EPS / Sales Surprises
Enter Ticker Symbol:   Ticker Lookup Company Quote Company Profile Research Summary EPS Consensus Perspective Insider Transactions Price Performance

Enter any portion of the company’s name to find its corresponding ticker symbol:

Search for :

Zacks Company Profile for ZIVO Bioscience, Inc. (ZIVO : OTC)

• Company Description    Zivo Bioscience Inc., is a R&D firm. It engaged in study, development and commercialization of natural nutritional compounds and bioactive molecules derived from proprietary algal strains. Zivo Bioscience Inc. is headquartered in Keego Harbor, Michigan. Number of Employees: 7

• Price / Volume Information    Yesterday's Closing Price: $8.70 Daily Weekly Monthly 20 Day Moving Average: 1,672 shares Shares Outstanding: 3.94 (millions) Market Capitalization: $34.27 (millions) Beta: 0.20 52 Week High: $22.00 52 Week Low: $6.95 Short Interest Ratio:   % Price Change % Price Change Relative to S&P 500 4 Week -13.00% -12.85% 12 Week -33.13% -34.21% Year To Date 0.00% 0.00%

• Address & Contact Information Street Address Phone / Fax Email Address Web URL 2125 BUTTERFIELD DRIVE SUITE 100 - TROY,MI 48084 USA ph: 248-452-9866 fax: - tpatel@allianceadvisors.com http://www.zivobioscience.com

• General Corporate Information    Officers John B. Payne - Chief Executive Officer; President and Director Keith R. Marchiando - Chief Financial Officer; and Secretary Christopher D. Maggiore - Director Nola E. Masterson - Director Alison A. Cornell - Director Peer Information ZIVO Bioscience, Inc. (CORR.) ZIVO Bioscience, Inc. (RSPI) ZIVO Bioscience, Inc. (CGXP) ZIVO Bioscience, Inc. (BGEN) ZIVO Bioscience, Inc. (GTBP) ZIVO Bioscience, Inc. (RGRX) Industry / Sector / Ticker Info Analyst Coverage: No Industry Group: MED-BIOMED/GENE Sector: Medical CUSIP: 98978N309 SIC: 2836 Fiscal Year Fiscal Year End: December Last Reported Quarter: 09/01/25 Next Expected EPS Date: 03/17/26 Share - Related Items Shares Outstanding: 3.94 Most Recent Split Date: 10.00 (0.17:1) Beta: 0.20 Market Capitalization: $34.27 (millions)

• EPS Information     • Dividend Information Analyst Coverage: No Dividend Yield: 0.00% Current Fiscal Quarter EPS Consensus Estimate: $ Indicated Annual Dividend: $0.00 Current Fiscal Year EPS Consensus Estimate: $ Payout Ratio: Number of Estimates in the Fiscal Year Consensus: Change In Payout Ratio: Estmated Long-Term EPS Growth Rate: % Last Dividend Paid: NA - $0.00 Next EPS Report Date: 03/17/26

• Fundamental Ratios P/E Current FY Estimate: - Trailing 12 Months: - PEG Ratio: - Price Ratios Price/Book: - Price/Cash Flow: - Price / Sales: - EPS Growth vs. Year Ago Period: 59.70% vs. Previous Quarter: 37.21% Sales Growth vs. Year Ago Period: 106.25% vs. Previous Quarter: 24.53% ROE 12/31/25 - - 09/30/25 - - 06/30/25 - - ROA 12/31/25 - - 09/30/25 - -801.23 06/30/25 - -931.80 Current Ratio 12/31/25 - - 09/30/25 - 0.08 06/30/25 - 0.14 Quick Ratio 12/31/25 - - 09/30/25 - 0.08 06/30/25 - 0.14 Operating Margin 12/31/25 - - 09/30/25 - - 06/30/25 - - Net Margin 12/31/25 - - 09/30/25 - - 06/30/25 - - Pre-Tax Margin 12/31/25 - - 09/30/25 - -4,060.29 06/30/25 - -5,555.43 Book Value 12/31/25 - - 09/30/25 - -0.85 06/30/25 - -0.67 Inventory Turnover 12/31/25 - - 09/30/25 - - 06/30/25 - - Debt-to-Equity 12/31/25 - - 09/30/25 - - 06/30/25 - - Debt-to-Capital 12/31/25 - - 09/30/25 - - 06/30/25 - -

Powered by Zacks Investment Research ©